USP22 overexpression is detected in many human tumors, including non-small cell lung cancer, salivary duct carcinoma, bladder cancer, colorectal cancer, oral squamous cell carcinoma, and esophageal squamous cell carcinoma [5–11]. This evidence concerns the gene USP22 and urinary bladder carcinoma.